FDA ISSUES NEW MAMMOGRAPHY GUIDELINES FOR WOMEN WITH DENSE BREASTS

New regulations will improve early detection and raise awareness among health care providers.

In an effort to help more women with dense breasts understand their screening options, the Food and Drug Administration on March 9 updated its mammography guidelines to require mammography facilities to notify patients about the density of their breasts. The new rule amends regulations issued under the Mammography Quality Standards Act of 1992, a law passed to ensure quality mammography. The amendments are required to be implemented within 18 months.

For her innovative research on how cannabinoids affect the tumor immune microenvironment in melanoma, Camille Stewart, MD, an assistant professor in the Division of Surgical Oncology, has been named to the 2023 cohort of the National Cancer Institute’s Early-Stage Surgeon Scientist Program (ESSP). The National Cancer Institute coordinates the United States National Cancer Program and is part of the National Institutes of Health.